Expression of the dopamine transporter gene is regulated by the 3′ UTR VNTR:: Evidence from brain and lymphocytes using quantitative RT-PCR

被引:284
作者
Mill, J [1 ]
Asherson, P [1 ]
Browes, C [1 ]
D'Souza, U [1 ]
Craig, I [1 ]
机构
[1] Inst Psychiat, Social Genet & Dev Res Ctr, London SE5 8AF, England
来源
AMERICAN JOURNAL OF MEDICAL GENETICS | 2002年 / 114卷 / 08期
关键词
dopamine transporter gene; (DAT1); VNTR; expression; quantitative RT-PCR; TaqMan; attention deficit hyperactivity disorder;
D O I
10.1002/ajmg.b.10948
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Genetic association studies provide considerable evidence that the 10-repeat allele of a variable number tandem repeat (VNTR) in the 3'-untranslated region (3'-UTR) of the dopamine transporter gene (DAT1) is associated with a range of psychiatric phenotypes, most notably, attention deficit hyperactivity disorder. The mechanism for this association is not yet understood, although several lines of evidence implicate variation in gene expression. In this study, we measured DAT1 messenger RNA levels in cerebellum, temporal lobe, and lymphocytes using quantitative real-time reverse-transcription polymerase chain reaction. Relative to a set of four control housekeeping genes (beta-actin, GAPD, ribosomal 18S, and beta2-microglobulin) we observed that increased levels of DAT1 expression were associated with the number of 10-repeat alleles. These data provide direct evidence that the VNTR, or another polymorphism in linkage disequilibrium with the VNTR, is involved in regulating expression of this gene. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:975 / 979
页数:5
相关论文
共 24 条
[1]   Identification of dopamine plasma membrane and vesicular transporters in human peripheral blood lymphocytes [J].
Amenta, F ;
Bronzetti, E ;
Cantalamessa, F ;
El-Assouad, D ;
Felici, L ;
Ricci, A ;
Tayebati, SK .
JOURNAL OF NEUROIMMUNOLOGY, 2001, 117 (1-2) :133-142
[2]   Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention-deficit/hyperactivity disorder [J].
Barr, CL ;
Xu, C ;
Kroft, J ;
Feng, Y ;
Wigg, K ;
Zai, G ;
Tannock, R ;
Schachar, R ;
Malone, M ;
Roberts, W ;
Nöthen, MM ;
Grünhage, F ;
Vandenbergh, DJ ;
Uhl, G ;
Sunohara, G ;
King, N ;
Kennedy, JL .
BIOLOGICAL PSYCHIATRY, 2001, 49 (04) :333-339
[3]  
CHEN K, IN PRESS MOL PSYCHIA
[4]  
COOK EH, 1995, AM J HUM GENET, V56, P993
[5]   Association study of a dopamine transporter polymorphism and attention deficit hyperactivity disorder in UK and Turkish samples [J].
Curran, S ;
Mill, J ;
Tahir, E ;
Kent, L ;
Richards, S ;
Gould, A ;
Huckett, L ;
Sharp, J ;
Batten, C ;
Fernando, S ;
Ozbay, F ;
Yazgan, Y ;
Simonoff, E ;
Thompson, M ;
Taylor, E ;
Asherson, P .
MOLECULAR PSYCHIATRY, 2001, 6 (04) :425-428
[6]   Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children [J].
Daly, G ;
Hawi, Z ;
Fitzgerald, M ;
Gill, M .
MOLECULAR PSYCHIATRY, 1999, 4 (02) :192-196
[7]   Dopamine transporter density in patients with attention deficit hyperactivity disorder [J].
Dougherty, DD ;
Bonab, AA ;
Spencer, TJ ;
Rauch, SL ;
Madras, BK ;
Fischman, AJ .
LANCET, 1999, 354 (9196) :2132-2133
[8]   Attention deficit hyperactivity disorder:: binding of [99mTC]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment [J].
Dresel, S ;
Krause, J ;
Krause, KH ;
LaFougere, C ;
Brinkbäumer, K ;
Kung, HF ;
Hahn, K ;
Tatsch, K .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2000, 27 (10) :1518-1524
[9]  
Fuke S., 2001, Pharmacogenomics Journal, V1, P152
[10]   Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism [J].
Gill, M ;
Daly, G ;
Heron, S ;
Hawi, Z ;
Fitzgerald, M .
MOLECULAR PSYCHIATRY, 1997, 2 (04) :311-313